The global microfluidics market is expected to reach USD
10 billion by 2024, according to a new report by Grand View Research, Inc. The
demand for this sector is expected to upsurge due to the introduction of
improved technology, such as digital microfluidics, which enables on-chip
biochemical analysis.
Industry players are introducing newer sampling
technologies to meet the demand for screening a huge number of biological
samples. For instance, in March 2014, Dolomite launched Mitos Dropix capable of
generating miniature droplets to isolate contents. The patented droplet picking
technology enables high-throughput sample screening.
Moreover, researchers are continuously striving to
come up with improved sample droplet production techniques. For instance,
Columbia University introduced the picoliter fluid dispensation technology.
This lab-on-chip technology could deliver sample volume less than 50 nL.
Integrating microfluidics with multiplexed sensing technology allows multiple
sample analytical application.
Browse full report by Grand View Research
: http://www.grandviewresearch.com/industry-analysis/microfluidics-market
Further Key Findings From the Study
Suggests:
- In Vitro Diagnostic (IVD) segment dominated the
application segment owing to the increasing adoption of microfluidics in
this market. Moreover, the leaders in the diagnostics sector, such
as Abbott, Roche, and Danaher are encouraging the use of newer
microfluidics technologies, such as the monodisperse bubbles/drops.
- Novel drug delivery system requires the administration
of the drug in the form of nanoparticles, thereby reducing the onset of
action. Devices such as microneedles, pumps, and inhalers are expected to
experience fastest growth during the forecasted period.
- Polymers had the largest revenue share in 2015.
Polymers offer better temperature control as compared to glass. However,
silicon material is expected to witness fastest growth owing to the
dominance of point-of-care diagnostics in the microfluidics market.
Moreover, the growing demands for faster results with minimally invasive
tools are expected to boost growth of this sector.
- North America dominated the market in 2015. It is
attributed to the presence of strong research capital, introduction of
improved sample volume screening techniques, and presence of dominant
market players.
- In June 2016, Roche received 510 (K) clearances for
Elecsys BRAHMS PCT assay. With this launch, Roche became the only company
to offer integrated solutions: the assessment and management of sepsis
risk. The biomarker was developed to offer a solution for the 1.6 million
annual hospitalizations.
- Asia Pacific is expected to witness fastest growth
owing to the increasing aging population, repeated hospital visits,
presence of untapped market, and the low cost of labor. These factors have
attracted many international players to establish their research
laboratories in India and China.
- The industry is also experiencing many mergers and
acquisitions between competitors. In July 2015, IDEX Corporation acquired
CIDRA Precision Services, LLC. CIDRA Precision Services, LLC is a
manufacturer of microfluidics devices and the acquisition is expected to
accelerate IDEX growth in the microfluidics space.
- Some key players are Illumina, Inc.; Agilent
Technologies; Caliper Life Sciences (acquired by PerkinElmer, Inc.);
Cepheid; Danaher Corporation; Life Technologies Corporation (acquired by
Thermo Fisher Scientific, Inc.);Bio-Rad Laboratories, Inc.; Abbott Laboratories;
F. Hoffmann-La Roche Ltd; and Fluidigm Corporation.
Browse more reports of this category by
Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global
microfluidics market on the basis of application, material and region:
Microfluidics Application Outlook
(Revenue, USD Million, 2013 - 2024)
- Pharmaceutical
- Genomics
- Proteomics
- Cell based assays and others
- In-Vitro Diagnostics (IVD)
- POC
- Clinical
- Environmental and industrial
- Medical Devices
Microfluidics Material Outlook (Revenue,
USD Million, 2013 - 2024)
- Polymer
- Glass
- Silicon
- Metal, Ceramics and others
Microfluidics Regional Outlook (Revenue,
USD Million, 2013 - 2024)
- North America
- S.
- Canada
- Europe
- UK
- Germany
- Rest of Europe
- Asia Pacific
- India
- Japan
- China
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- MEA
- South Africa
Access press release by Grand View
Research: http://www.grandviewresearch.com/press-release/global-microfluidics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more
information: http://www.grandviewresearch.com
No comments:
Post a Comment